Literature DB >> 396667

Human monocyte-mediated cytotoxicity to K-562 cells: activation by lymphokines.

J Hammerstrøm.   

Abstract

Human monocytes purified by adherence and prolonged in vitro monolayer culture were activated by supernatants of autologous lymphocytes stimulated with live bacillus Calmette-Guérin or killed Corynebacterium parvum. Activated monocytes expressed increased ability to lyse K-562 cells prelabelled with methyl-3H-thymidine in a 48 h assay. Activation could be detected at a 1:64 dilution of lymphokine supernatants. Target cell killing by activated monocytes was strongly influenced by the density of the monocyte monolayer. Monocytes at an intermediate stage of in vitro differentiation seemed to be most response to lymphokine activation. Morphological studies indicated that a considerable number of K-562 cells attach firmly to monocytes. The monocyte-mediated lysis of K-562 seems to be extracellular, as phagocytosis was not observed. Freshly isolated adherent blood mononuclear cells (greater than 90% monocytes) were strongly cytostatic to K-562 cells, as determined by inhibition of methyl-3H-thymidine uptake. Considerable cytolytic activity was also found with freshly isolated adherent cells, strong enhancement being produced by performing the assay in the presence of newborn calf serum, as opposed to human AB serum.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 396667     DOI: 10.1111/j.1365-3083.1979.tb01392.x

Source DB:  PubMed          Journal:  Scand J Immunol        ISSN: 0300-9475            Impact factor:   3.487


  14 in total

1.  The role of monocyte cytotoxic factor in monocyte-mediated lysis of tumour cells.

Authors:  T Espevik; O Kildahl-Andersen; J Nissen-Meyer
Journal:  Immunology       Date:  1986-02       Impact factor: 7.397

2.  Monocyte-mediated drug-dependent cellular cytotoxicity: effects on different WEHI 164 target cell lines.

Authors:  R Austgulen; O Kildahl-Andersen; T Espevik
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

3.  Cytostatic activity on tumour cells of monocytes from patients with gastrointestinal cancer.

Authors:  B Mytar; M Zembala; W Uracz; A Czupryna
Journal:  Cancer Immunol Immunother       Date:  1982       Impact factor: 6.968

4.  Effect of lipopolysaccharides, lipid A and interferon on the cell-mediated cytotoxicity of human leukocytes against K-562 tumor cells.

Authors:  P C Fink; C Klaproth; H H Peter
Journal:  Infection       Date:  1984 Sep-Oct       Impact factor: 3.553

5.  Human serum induces maturation of human monocytes in vitro. Changes in cytolytic activity, intracellular lysosomal enzymes, and nonspecific esterase activity.

Authors:  R A Musson
Journal:  Am J Pathol       Date:  1983-06       Impact factor: 4.307

6.  Oncostatin M: a growth regulator produced by differentiated histiocytic lymphoma cells.

Authors:  J M Zarling; M Shoyab; H Marquardt; M B Hanson; M N Lioubin; G J Todaro
Journal:  Proc Natl Acad Sci U S A       Date:  1986-12       Impact factor: 11.205

7.  Physicochemical characterization of cytostatic factors released from human monocytes.

Authors:  J Nissen-Meyer; J Hammerstrøm
Journal:  Infect Immun       Date:  1982-10       Impact factor: 3.441

8.  Defective interleukin-1 production by monocytes from patients with malignant disease. Interferon increases IL-1 production.

Authors:  J Herman; M C Kew; A R Rabson
Journal:  Cancer Immunol Immunother       Date:  1984       Impact factor: 6.968

9.  Tumour necrosis factor-like activity on paraformaldehyde-fixed monocyte monolayers.

Authors:  T Espevik; J Nissen-Meyer
Journal:  Immunology       Date:  1987-08       Impact factor: 7.397

10.  Interferon as a macrophage activating factor. I. Enhancement of cytotoxicity by fresh and matured human monocytes in the absence of other soluble signals.

Authors:  R T Dean; J L Virelizier
Journal:  Clin Exp Immunol       Date:  1983-03       Impact factor: 4.330

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.